The company, which is an artificial intelligence software platform focused on heart disease, plans to sell 12.5 million shares in a marketing range of $15 to $17 each, according to a filing Friday with the US Securities and Exchange Commission.
At the top of the range, Heartflow would command a market value of $1.32 billion based on the number of shares listed in the filing.
Heartflow’s platform aims to make ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.